glp-1 injections compounded semaglutide Hims & Hers stock falls 25% as FDA curtails GLP-1s GLP-1 and GLP-1/GIP Starter Bundle
Description
This underscores the uncertainty surrounding the long-term effects of these agents, which patients may need to take indefinitely to sustain weight loss

Key Benefits : Average weight loss of 13 15% at 68 weeks in clinical trials

Under 18s : While some limited paediatric licenses exist (such as Saxenda for ages 12+), most GLP-1s are not for minors

Reach out to La Jolla Recovery today to learn how our team can support your recovery with the most current, evidence-based methods available

The risk of these adverse outcomes can be reduced by optimal glycemic control and healthy weight (7)

Victoza lawsuits are being filed because patients allege that the drug manufacturer failed to provide adequate warnings about serious health risks associated with the medication
